<DOC>
	<DOC>NCT00195715</DOC>
	<brief_summary>To evaluate the long-term maintenance of response, safety and tolerability of repeated administration of adalimumab in subjects with Crohn's disease who participated in and successfully completed Protocol M02-404 or Protocol M04-691.</brief_summary>
	<brief_title>Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Subject must have successfully completed either the M02404 (NCT00077779) or M04691 (NCT00105300) protocol to be eligible for this study Diagnosis of Crohn's disease Willing and able to give informed consent Diagnosis of ulcerative colitis Women cannot be pregnant or breastfeeding Previous history of listeria infection or untreated tuberculosis Previous history of cancer other than successfully treated skin cancer or carcinomainsitu of the cervix</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>